Partner
Jonathan has a degree in chemistry and a doctorate in synthetic chemistry from Oxford University. Jonathan’s doctoral thesis was sponsored by Glaxo Group Research. His research was concerned with the stereoselective synthesis of a number of alkaloid derivatives, including derivatives of morphine, having therapeutic applications.
Jonathan has worked both in private practice, and in-house, in the patent department of a multinational pharmaceutical company prior to joining HGF. His practice draws on this experience and extends to a wide range of chemical and mechanical subject matter. Jonathan’s practice in the pharmaceutical area has covered the protection of new chemical entities, novel formulations and polymorphic forms, new medical uses for therapeutics, and process and development issues. He has a number of years experience in filing supplementary protection certificates for marketed pharmaceutical drugs. Jonathan’s clients include both large and small companies, universities and government funded organisations.
His extensive experience in patent and related matters also covers fine chemicals and process development, medical devices and diagnostic tools, and technical materials such as alloys, ceramics, polymers, semiconductors and nanotubes.
Jonathan’s practice involves providing commercially focused advice to business managers and to R&D groups on all aspects of patent strategy and portfolio management. This includes obtaining and defending patent rights, providing opinions on freedom to operate where third party intellectual property rights exist, challenging third party patent rights and conducting due diligence to support corporate acquisition and licensing deals.
VIEW FULL PROFILE
